发明公开
EP2972386A2 NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF 有权
FOR非酒精性脂肪肝疾病生物标志及其用途及酒精性脂肪性肝炎

  • 专利标题: NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF
  • 专利标题(中): FOR非酒精性脂肪肝疾病生物标志及其用途及酒精性脂肪性肝炎
  • 申请号: EP14717266.2
    申请日: 2014-03-10
  • 公开(公告)号: EP2972386A2
    公开(公告)日: 2016-01-20
  • 发明人: NIKRAD, MaltiFIELD, Stuart G.WILLIAMS, Stephen Alaric
  • 申请人: Somalogic, Inc.
  • 申请人地址: 2945 Wilderness Place Boulder, CO 80301 US
  • 专利权人: Somalogic, Inc.
  • 当前专利权人: Somalogic, Inc.
  • 当前专利权人地址: 2945 Wilderness Place Boulder, CO 80301 US
  • 代理机构: Clegg, Richard Ian
  • 优先权: US201361787967P 20130315
  • 国际公布: WO2014150198 20140925
  • 主分类号: G01N33/68
  • IPC分类号: G01N33/68
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF
摘要:
Methods, compositions, and kits for determining whether a subject has non-alcoholic fatty liver disease (NAFLD) are provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatosis are also provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatohepatitis (NASH) are also provided.
信息查询
0/0